Technical Analysis for ZYXI - Zynex, Inc.

Grade Last Price % Change Price Change
D 10.15 2.32% 0.23
ZYXI closed up 2.32 percent on Friday, May 31, 2024, on 1.16 times normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Flat Down Down

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
Multiple of Ten Bullish Other 0.00%
Outside Day Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Multiple of Ten Bearish Other 2.32%
Outside Day Range Expansion 2.32%
Down 3 Days in a Row Weakness 2.32%
Oversold Stochastic Weakness 2.32%
Multiple of Ten Bullish Other 1.30%

   Recent Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Zynex, Inc. Description

Zynex, Inc., a medical technology company, designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. Its products include NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; and InWave, an electrical stimulation product for the treatment of female urinary incontinence. The company also distributes private labeled products, such as electrodes for the delivery of electrical current to the body; batteries for use in electrotherapy products; Comfortrac for cervical traction; JetStream for hot/cold therapy; and LSO Back Braces for lumbar support. In addition, it develops non-invasive blood volume monitors for use in hospitals and surgery centers. The company offers its products for pain management and control; and stroke and spinal cord injury rehabilitation. It sells its products through direct and independent sales representatives primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Pain Surgery Batteries Medical Technology Pain Management Stroke Neuromodulation Neurophysiology Analgesics Neurotechnology Nerve Electrophysiology Spinal Cord Urinary Incontinence Electrotherapy Blood Volume Cold Therapy Electrotherapy Products Spinal Cord Injury Transcutaneous Electrical Nerve Stimulation

Is ZYXI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.77
52 Week Low 6.88
Average Volume 118,164
200-Day Moving Average 10.20
50-Day Moving Average 11.41
20-Day Moving Average 10.56
10-Day Moving Average 10.35
Average True Range 0.34
RSI (14) 38.65
ADX 30.95
+DI 12.09
-DI 30.72
Chandelier Exit (Long, 3 ATRs) 11.15
Chandelier Exit (Short, 3 ATRs) 10.90
Upper Bollinger Bands 11.23
Lower Bollinger Band 9.90
Percent B (%b) 0.19
BandWidth 12.59
MACD Line -0.36
MACD Signal Line -0.34
MACD Histogram -0.0247
Fundamentals Value
Market Cap 344.09 Million
Num Shares 33.9 Million
EPS 0.43
Price-to-Earnings (P/E) Ratio 23.60
Price-to-Sales 2.27
Price-to-Book 7.19
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.64
Resistance 3 (R3) 10.60 10.40 10.56
Resistance 2 (R2) 10.40 10.28 10.42 10.53
Resistance 1 (R1) 10.28 10.20 10.34 10.31 10.50
Pivot Point 10.07 10.07 10.11 10.09 10.07
Support 1 (S1) 9.95 9.95 10.01 9.99 9.80
Support 2 (S2) 9.75 9.87 9.77 9.77
Support 3 (S3) 9.62 9.75 9.74
Support 4 (S4) 9.66